Patents by Inventor Benoit Grellier

Benoit Grellier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody against the CSF-1R
    Patent number: 9982055
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: May 29, 2018
    Assignee: TRANSGENE S.A.
    Inventors: Hélène Haegel, Christine Thioudellet, Michel Geist, Benoit Grellier, Jean-Baptiste Marchand
  • ANTIBODY AGAINST THE CSF-1R
    Publication number: 20170002081
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Application
    Filed: July 19, 2016
    Publication date: January 5, 2017
    Inventors: Hélène HAEGEL, Christine Thioudellet, Michel Geist, Benoit Grellier, Jean-Baptiste Marchand
  • Biomarker for treating cancer patients
    Patent number: 9261512
    Abstract: The present invention concerns biomarkers and use thereof for determining whether a subject is or is not susceptible to developing a prophylactic or therapeutic immune response after such treatment.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: February 16, 2016
    Assignee: Transgene, S.A.
    Inventors: Bruce Acres, Benoit Grellier
  • ANTIBODY AGAINST THE CFR-1R
    Publication number: 20130289250
    Abstract: The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.
    Type: Application
    Filed: May 17, 2013
    Publication date: October 31, 2013
    Applicant: TRANSGENE, S.A.
    Inventors: Helene HAEGEL, Christine THIOUDELLET, Michel GEIST, Benoit GRELLIER, Jean-Baptiste MARCHAND
  • Biomarker for Selecting Patients and Related Methods
    Publication number: 20120115249
    Abstract: The present invention concerns biomarkers and use thereof for determining whether a subject is or is not susceptible to developing a prophylactic or therapeutic immune response after such treatment.
    Type: Application
    Filed: July 6, 2010
    Publication date: May 10, 2012
    Inventors: Bruce Acres, Benoit Grellier